Estimating Fluid Requirement in Shocked Traumatic Patients by US on SCV
Launched by ASSIUT UNIVERSITY · Dec 9, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective an ultrasound technique called the SCV (Superior Vena Cava) collapsibility index is in estimating the fluid needs of patients who are in shock due to trauma. Shock is a serious condition where the body doesn’t get enough blood flow, often requiring immediate medical attention. The researchers want to see if measuring the collapsibility of the SCV can help doctors decide how much fluid these patients will need in the first 24 hours after treatment begins.
To participate in the study, individuals must be traumatic patients admitted to the emergency department at Assiut University Hospital between March 2025 and March 2026. Eligible participants are typically aged between 18 and 60, and they cannot be pregnant or have certain medical conditions that would prevent them from receiving fluid treatments. If someone agrees to participate, they can expect to undergo ultrasound tests before and after the first hour of their treatment to help doctors make better decisions about their care. It’s important to know that participation is completely voluntary, and patients or their families can choose not to be part of the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Traumatic patients who will come to emergency department at Assiut university Hospital between march 2025 to march 2026 and will be admitted after stabilization to the Inpatient ward or ICU
- Exclusion Criteria:
- • Patients or their Relatives refuse participation in the study.
- • Patients who will be transferred to another hospital
- • • Pregnant women.
- • Age below 18 and more than 60.
- • Failure of follow-up of any patient.
- • Cardiopulmonary resuscitation on arrival.
- • Contraindicating fluid challenges, such as cardiac insufficiency and Renal failure .
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Trial Officials
Mohamed A Mohamed Abdelhameed, Resident
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported